Systematic review with network meta-analysis of maintenance therapy in newly diagnosed multiple myeloma: lenalidomide, proteasome inhibitors and CD38 antibodies improved PFS, but OS benefit appeared only with lenalidomide in transplant-eligible patients.
Meta-analysis
Ludwig et al. The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)